Drug details

Wynzora (calcipotriene and betamethasone dipropionate cream)

type of Corticosteroids, Topical, Vitamin D Analogs

Wynzora (calcipotriene and betamethasone dipropionate cream) is a combination of a vitamin D analog and a corticosteroid used for the topical treatment of plaque psoriasis in patients 18 years of age and older.

This drug may have the following side effects:

• headache, and
• upper respiratory infection,
• application site irritation

The following drugs are related to Wynzora, either as a replacement or used together:

• Soriatane (acitretin)
• Humira (adalimumab injection solution for subcutaneous administration)
• Enstilar (calcipotriene and betamethasone dipropionate foam, 0.005%/0.064%)
• Vectical Ointment (calcitriol ointment)
• Vanos (fluocinonide)
• Tremfya (guselkumab for injection)
• H.P. Acthar Gel (repository corticotropin injection)
• Pandel (hydrocortisone probutate cream)
• Ilumya (tildrakizumab-asmn injection, for subcutaneous use)
• Remicade (infliximab)
• Taltz (ixekizumab injection, for subcutaneous use)
• Kenalog 10 Injection (triamcinolone acetonide injectable suspension)
• Rasuvo (methotrexate non-pyrogenic solution for a single subcutaneous injection)
• Otrexup (methotrexate injection)
• Skyrizi (risankizumab-rzaa injection)
• Stelara Injection (ustekinumab)